Abstract:BACKGROUNDIt is well known that a significant number of prostate cancers (PCa) showed different extents of radio-resistance and the tumor may recur after treatment. Recent studies demonstrated that Testicular orphan nuclear receptor 4 (TR4) could play a critical role in anti-oxidative stress responses and might modulate the DNA damage repair. The objective of this study is to investigate the role of TR4 in the radiotherapy for PCa. METHODSThe TR4 expression in tissue samples from PCa patients treated with brachytherapy was measured by immunohistochemistry (IHC). Cell survival test and colony formation assay were applied to test the radio-sensitivity of PCa cells with modulated TR4 gene expression upon irradiation. RESULTSPCa patients with biochemical recurrence (BCR) after brachytherapy tend to have higher TR4 expression (80%, n=30) as compared to those without BCR (36.67%, n=30). Survival analysis demonstrated a significant higher BCR occurrence in patients with high level of TR4 expression (HR=3.474, 95%CI 1.678-7.192, P=0.0008). Multivariate analysis showed that the TR4 staining score on IHC was the only significant variable for predicting the PCa patients' clinical outcomes after radiotherapy (OR=9.919, 95% CI 2.516-39.101, P=0.001). Using cell survival test and colony forming assay, we found that the addition of functional TR4 in PC3 cells lead to elevated radio-resistance. In contrast, knocking-down TR4 in LNCaP cells resulted in increased radio-sensitivity. The H2AX foci kinetic analysis suggested that knocking down TR4 might delay the PCa cell's DNA damage repair which would enhance the radio-sensitivity. CONCLUSIONTR4 could mediate the PCa cells' radio-sensitivity and might become a prognostic indicator for PCa patients received radiotherapy. This study provides a novel approach to manipulate radio-sensitivity of PCa cells, and may bring a promoted therapeutic outcome of radiotherapy to battle PCa in future. Prostate 75:1632-1642, 2015. (c) 2015 Wiley Periodicals, Inc.

Supplementary Figure 2 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion Via Modulating the EZH2-Related Metastasis Gene Expression

Supplementary Figure 1 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression

Testicular Orphan Nuclear Receptor 4 is Associated with the Radio-Sensitivity of Prostate Cancer.

Supplementary Table 1 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion Via Modulating the EZH2-Related Metastasis Gene Expression

Supplementary Figure Legends from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion Via Modulating the EZH2-Related Metastasis Gene Expression

TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion Via Modulating the EZH2-Related Metastasis Gene Expression

Increased Chemosensitivity Via Targeting Testicular Nuclear Receptor 4 (Tr4)-Oct4-interleukin 1 Receptor Antagonist (il1ra) Axis in Prostate Cancer CD133+ Stem/progenitor Cells to Battle Prostate Cancer.

TR4 Nuclear Receptor Increases Prostate Cancer Invasion Via Decreasing the Mir-373-3p Expression to Alter TGFβR2/p-Smad3 Signals.

TR4 Nuclear Receptor Enhances the Cisplatin Chemo-Sensitivity Via Altering the ATF3 Expression to Better Suppress HCC Cell Growth

TR4 Nuclear Receptor Promotes Prostate Cancer Metastasis Via Upregulation of CCL2/CCR2 Signaling.

Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer <i>via</i> Bcl-2

Targeting TR4 Nuclear Receptor Suppresses Prostate Cancer Invasion Via Reduction of Infiltrating Macrophages with Alteration of the TIMP-1/MMP2/MMP9 Signals

TR4 Nuclear Receptor Enhances Prostate Cancer Initiation Via Altering the Stem Cell Population and EMT Signals in the PPARG-deleted Prostate Cells.

Supplementary Table 1 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Figures from Infiltrating Macrophages Promote Prostate Tumorigenesis Via Modulating Androgen Receptor-Mediated CCL4–STAT3 Signaling

Supplementary Figure 2 from &Lt;i>fra-1&Lt;/i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from Chimeric Transcript Generated by Cis-Splicing of Adjacent Genes Regulates Prostate Cancer Cell Proliferation

Supplementary Figure 2 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figures 1-4 from M<sup>6</sup>a Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB